Patents by Inventor Stig Aasmul-Olsen

Stig Aasmul-Olsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Allergen dosage form
    Patent number: 10080719
    Abstract: The invention provides allergen containing pharmaceutical products and in particular fast-dispersing solid allergen dosage forms. In particular, fast-dispersing, non-compressed solid dosage forms suitable for oromucosal administration comprising a matrix and at least one allergen are provided. Suitable matrices are gelatine, starch and mannitol. Methods for the dosage forms are also provided.
    Type: Grant
    Filed: July 6, 2016
    Date of Patent: September 25, 2018
    Assignee: ALK-ABELLÓ A/S
    Inventors: Henrik Hugo Jacobi, Annette Roemmelmayer Lundegaard, Christian Gauguin Houghton, Stig Aasmul-Olsen, Lise Lund Maerkedahl, Jan Sondergaard Andersen
  • ALLERGEN DOSAGE FORM
    Publication number: 20160324767
    Abstract: The invention provides allergen containing pharmaceutical products and in particular fast-dispersing solid allergen dosage forms. In particular, fast-dispersing, non-compressed solid dosage forms suitable for oromucosal administration comprising a matrix and at least one allergen are provided. Suitable matrices are gelatine, starch and mannitol. Methods for the dosage forms are also provided.
    Type: Application
    Filed: July 6, 2016
    Publication date: November 10, 2016
    Applicants: ALK-Abello A/S, R.P. Scherer Technologies, LLC
    Inventors: Henrik Hugo Jacobi, Annette Roemmelmayer Lundegaard, Christian Gauguin Houghton, Stig Aasmul-Olsen, Lise Lund Maerkedahl, Jan Sondergaard Andersen, Kerry Mallindine, Owen James Murray, Susan Gerrard Banbury, Desmond Yik Teng Wong, Lisa Marie Garrett, Michael Hall
  • Allergen dosage form
    Patent number: 9415015
    Abstract: The invention provides allergen containing pharmaceutical products and in particular fast-dispersing solid allergen dosage forms. In particular, fast-dispersing, non-compressed solid dosage forms suitable for oromucosal administration comprising a matrix and at least one allergen are provided. Suitable matrices are gelatine, starch and mannitol. Methods for the dosage forms are also provided.
    Type: Grant
    Filed: April 4, 2008
    Date of Patent: August 16, 2016
    Assignees: ALK-Abello A/S, R.P. Scherer Technologies, LLC
    Inventors: Henrik Hugo Jacobi, Annette Roemmelmayer Lundegaard, Christian Gauguin Houghton, Stig Aasmul-Olsen, Lise Lund Maerkedahl, Jan Sondergaard Andersen, Kerry Mallindine, Owen James Murray, Susan Gerrard Banbury, Desmond Yik Teng Wong, Lisa Marie Garrett, Michael Hall
  • Allergen dosage form
    Patent number: 9408805
    Abstract: The invention provides allergen containing pharmaceutical products and in particular fast-dispersing solid allergen dosage forms. In particular, fast-dispersing, non-compressed solid dosage forms suitable for oromucosal administration comprising a matrix and at least one allergen are provided. Suitable matrices are gelatine, starch and mannitol. Methods for the dosage forms are also provided.
    Type: Grant
    Filed: May 27, 2014
    Date of Patent: August 9, 2016
    Assignees: ALK-Abello A/S, R.P. Scherer Technologies, LLC
    Inventors: Henrik Hugo Jacobi, Annette Roemmelmayer Lundegaard, Christian Gauguin Houghton, Stig Aasmul-Olsen, Lise Lund Maerkedahl, Jan Sondergaard Andersen, Kerry Mallindine, Owen James Murray, Susan Gerrard Banbury, Desmond Yik Teng Wong, Lisa Marie Garrett, Michael Hall
  • ALLERGEN DOSAGE FORM
    Publication number: 20140271722
    Abstract: The invention provides allergen containing pharmaceutical products and in particular fast-dispersing solid allergen dosage forms. In particular, fast-dispersing, non-compressed solid dosage forms suitable for oromucosal administration comprising a matrix and at least one allergen are provided. Suitable matrices are gelatine, starch and mannitol. Methods for the dosage forms are also provided.
    Type: Application
    Filed: May 27, 2014
    Publication date: September 18, 2014
    Applicants: ALK-Abello A/S, R.P. Scherer Technologies, LLC
    Inventors: Henrik Hugo Jacobi, Annette Roemmelmayer Lundegaard, Christian Gauguin Houghton, Stig Aasmul-Olsen, Lise Lund Maerkedahl, Jan Sondergaard Andersen, Kerry Mallindine, Owen James Murray, Susan Gerrard Banbury, Desmond Yik Teng Wong, Lisa Marie Garrett, Michael Hall
  • Allergen dosage form
    Patent number: 8329196
    Abstract: The invention provides allergen containing pharmaceutical products and in particular fast-dispersing solid allergen dosage forms. In particular, fast-dispersing, non-compressed solid dosage forms suitable for oromucosal administration comprising a matrix and at least one allergen are provided. Suitable matrices are gelatine, starch and mannitol. Methods for the dosage forms are also provided.
    Type: Grant
    Filed: April 4, 2008
    Date of Patent: December 11, 2012
    Assignees: ALK-Abello A/S, R.P. Scherer Technologies, LLC
    Inventors: Henrik Hugo Jacobi, Annette R. Lundegaard, Christian Gauguin Houghton, Stig Aasmul-Olsen, Lise Lund Maerkedahl, Jan Sondergaard Andersen, Kerry Mallindine, Owen James Murray, Susan Gerrard Banbury, Desmond Yik Teng Wong, Lisa Marie Garrett, Michael Hall
  • Parenteral vaccine formulations and uses thereof
    Patent number: 7785611
    Abstract: Parenteral vaccine formulations and adjuvant compositions comprising certain salts as adjuvants are disclosed. Such parenteral vaccine formulations are used for generating an immune response in a subject following administration of the vaccine formulation or the adjuvant composition. Also disclosed is the use of these salts as adjuvants in parenteral vaccine formulations and adjuvant compositions, and to vaccine adjuvants comprising such salts.
    Type: Grant
    Filed: June 9, 2005
    Date of Patent: August 31, 2010
    Assignee: ALK-Abello A/S
    Inventors: Nanna Kristensen Soni, Janne Uldal Rahbek, Stig Aasmul-Olsen, Lise Lund
  • ALLERGEN DOSAGE FORM
    Publication number: 20080193535
    Abstract: The invention provides allergen containing pharmaceutical products and in particular fast-dispersing solid allergen dosage forms. In particular, fast-dispersing, non-compressed solid dosage forms suitable for oromucosal administration comprising a matrix and at least one allergen are provided. Suitable matrices are gelatine, starch and mannitol. Methods for the dosage forms are also provided.
    Type: Application
    Filed: April 4, 2008
    Publication date: August 14, 2008
    Applicant: Alk-Abello A/S
    Inventors: Henrik Hugo Jacobi, Annette R. Lundegaard, Christian G. Houghton, Stig Aasmul-Olsen, Lise L. Maerkedahl, Jan S. Andersen, Kerry Mallindin, Owen J. Murray, Susan G. Banbury, Desmond Yik Teng Wong, Lisa M. Garrett, Michael Hall
  • ALLERGEN DOSAGE FORM
    Publication number: 20080187558
    Abstract: The invention provides allergen containing pharmaceutical products and in particular fast-dispersing solid allergen dosage forms. In particular, fast-dispersing, non-compressed solid dosage forms suitable for oromucosal administration comprising a matrix and at least one allergen are provided. Suitable matrices are gelatine, starch and mannitol. Methods for the dosage forms are also provided.
    Type: Application
    Filed: April 4, 2008
    Publication date: August 7, 2008
    Applicant: ALK-Abello A/S
    Inventors: Henrik H. Jacobi, Annette R. Lundegaard, Christain G. Houghton, Stig Aasmul-Olsen, Lise L. Maerkedahl, Jan S. Andersen, Kerry Mallindine, Owen J. Murray, Susan G. Banbury, Desmond Yik Teng Wong, Lisa M. Garrett, Michael Hall
  • Novel parenteral vaccine formulations and uses thereof
    Publication number: 20050244420
    Abstract: Parenteral vaccine formulations and adjuvant compositions comprising certain salts as adjuvants are disclosed. Such parenteral vaccine formulations are used for generating an immune response in a subject following administration of the vaccine formulation or the adjuvant composition. Also disclosed is the use of these salts as adjuvants in parenteral vaccine formulations and adjuvant compositions, and to vaccine adjuvants comprising such salts.
    Type: Application
    Filed: June 9, 2005
    Publication date: November 3, 2005
    Applicant: ALK-Abello A/S
    Inventors: Nanna Soni, Janne Rahbek, Stig Aasmul-Olsen, Lise Lund
  • Allergen dosage form
    Publication number: 20040166123
    Abstract: The invention provides allergen containing pharmaceutical products and in particular fast-dispersing solid allergen dosage forms. In particular, fast-dispersing, non-compressed solid dosage forms suitable for oromucosal administration comprising a matrix and at least one allergen are provided. Suitable matrices are gelatine, starch and mannitol. Methods for the dosage forms are also provided.
    Type: Application
    Filed: November 26, 2003
    Publication date: August 26, 2004
    Inventors: Henrik H. Jacobi, Annette R. Lundegaard, Christian G. Houghton, Stig Aasmul-Olsen, Lise L. Maerkedahl, Jan S. Andersen, Kerry Mallindine, Owen J. Murray, Susan G Banbury, Desmond Yik Teng Wong, Lisa M. Garrett, Michael Hall
  • Novel parenteral vaccine formulations and uses thereof
    Publication number: 20020051794
    Abstract: Parenteral vaccine formulations and adjuvant compositions comprising certain salts as adjuvants are disclosed. Such parenteral vaccine formulations are used for generating an immune response in a subject following administration of the vaccine formulation or the adjuvant composition. Also disclosed is the use of these salts as adjuvants in parenteral vaccine formulations and adjuvant compositions, and to vaccine adjuvants comprising such salts.
    Type: Application
    Filed: August 9, 2001
    Publication date: May 2, 2002
    Applicant: ALK-ABELLO A/S
    Inventors: Nanna Kristensen Soni, Janne Uldal Rahbek, Stig Aasmul-Olsen, Lise Lund
  • Peptide derivative, pharmaceutical preparation containing it and method for treatment of glaucoma
    Patent number: 5411942
    Abstract: Peptide derivatives of 3-5 optionally substituted amino acids, a process for preparing the peptides, a pharmaceutical composition containing at least one peptide derivative active against glaucoma and intraocular hypertension and a method for treating glaucoma and intraocular hypertension.
    Type: Grant
    Filed: July 20, 1992
    Date of Patent: May 2, 1995
    Assignee: Carlbiotech Ltd. A/S
    Inventors: Fred Widmer, Kailash K. Gauri, Stig Aasmul-Olsen